Clinical practice guidelines are an important result of evidence-based research. However, current clinical practice remains out of step with the rapid pace of research advancements. Often, decades pass before research is translated into clinical practice. The National Comprehensive Cancer Network (NCCN) has created evidence-based clinical guidelines to promote effective clinical practice. Formerly, the NCCN established guidelines to reduce cancer-related infections only for neutropenic patients; however, they have expanded their guidelines beyond neutropenia to prevent and treat cancer-related infections. Implementing scientific evidence into clinical practice is challenging and complex, and healthcare professionals should understand barriers to implementing clinical practice guidelines to ensure successful translation into practice. This article provides a brief review of NCCN guidelines and describes common barriers encountered during implementation. In addition, a conceptual framework is offered to help identify and address potential concerns before and after adoption of guidelines. Sylvia K. Wood, DNP, ANP-BC, is a nurse practitioner in the
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In addition to improved patient care, concerns for the high cost of quality cancer care and variations in practice are significant factors driving development of clinical practice guidelines (Bach, 2007; Foster, Abdolrasulnia, Doroodchi, McClure, & Casebeer, 2009; Romanus et al., 2009; Soper, 2009) . Escalating costs of care have caused payers to pursue ways for standardizing care, increasing predictability, and decreasing costs by support and use of clinical guidelines in an effort to improve outcomes for all stakeholders (Shaffer, 2009) . Some payers are linking reimbursement for oncology therapies coverage to provider compliance of established clinical practice guidelines (Soper, 2009) . Despite compelling advances in guideline development, one should be mindful of the reality that the full impact of guideline implementation in a community-based oncology practice has not been measured. Unfortunately, efforts to translate rigorous high-quality research into clinical practice too often are met with only partial adoption or failed adoption into practice (Bradley et
